Paydirt
PQ
Insider

Paul T Quinlan

General Counsel

Paul T Quinlan (General Counsel) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Oruka Therapeutics, Inc. (ORKA). The largest single filing was $5.6M of ORKA (52,000 sh across 6 lots, as filed), executed Aug 14.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$6.5M
shares × price, as filed
Last traded
Sep 21
Filed yesterday

Median ADV $139.8M across their filed names

Open performance
Volume by month
$5.6M$2.8M$0Oct 2024Apr 2025Oct 2025Apr 2026Aug 2026 · sells $5.6MSep 2026 · sells $880K
Buys $0 Sells $6.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
ORKA Oruka Therapeutics, Inc. ORKA · 0 buys · 2 sells 2 filings
Recent filings
ORKASALE Oruka Therapeutics, Inc. View filing → $880K
9,399 sh across 3 lots
Exec Sep 21
Filed Sep 21 · 4:57 PM ET
ORKASALE Oruka Therapeutics, Inc. View filing → $5.6M
52,000 sh across 6 lots
Exec Aug 14
Filed Aug 14 · 5:52 PM ET